Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients

NCT06281912 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Perugia as lead sponsor.

NCT NCT06281912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06281912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients
Lead sponsor
Azienda Ospedaliera di Perugia
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2024
Completion date
November 30, 2024
Enrollment
70 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

advanced melanoma, early melanoma